Screening compound: InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2

Screening compound: InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2
Screening compound: InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K786-7208

Molecular Formula

C25H37N3O5S (C25 H37 N3 O5 S)

Compound Name

8-{[4-(4-benzylpiperidine-1-carbonyl)piperidin-1-yl]sulfonyl}-1,4-dioxa-8-azaspiro[4.5]decane

IUPAC name

8-{[4-(4-benzylpiperidine-1-carbonyl)piperidin-1-yl]sulfonyl}-14-dioxa-8-azaspiro[4.5]decane

SMILES

O=C(C(CC1)CCN1S(N(CC1)CCC11OCCO1)(=O)=O)N1CCC(Cc2ccccc2)CC1

MDL Number (MFCD)

InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2?
Check Price and Availability of InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C25H37N3O5S/c29-24(26-12-6-22(7-13-26)20-21-4-2-1-3-5-21)23-8-14-27(15-9-23)34(30,31)28-16-10-25(11-17-28)32-18-19-33-25/h1-5,22-23H,6-20H2 available by request